2-HYDROXY-5-(6-IODO-2-METHYL-4-OXO-3,4-DIHYDRO-3-QUINAZOLINYL)-BENZOYL-PROLYL-VALINE-METHYLESTER
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 3b3FUKzwWjj |
|---|---|
| InChI | InChI=1S/C27H29IN4O6/c1-14(2)23(27(37)38-4)30-24(34)21-6-5-11-31(21)25(35)19-13-17(8-10-22(19)33)32-15(3)29-20-9-7-16(28)12-18(20)26(32)36/h7-10,12-14,21,23,33H,5-6,11H2,1-4H3,(H,30,34) |
| InChIKey | UHKZWLBQPFQECJ-UHFFFAOYSA-N |
| Mol Weight | 632.46 g/mol |
| Molecular Formula | C27H29IN4O6 |
| Exact Mass | 632.11318 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
2-HYDROXY-5-(6-IODO-2-METHYL-4-OXO-3,4-DIHYDRO-3-QUINAZOLINYL)-BENZOYL-PROLYL-VALINE
2-HYDROXY-5-(6-IODO-2-METHYL-4-OXO-3,4-DIHYDRO-3-QUINAZOLINYL)-BENZOYL-HISTIDINYL-PHENYLALANINE-METHYLESTER
quinazoline-, 2-(diphenylmethyl)-4-(diphenylmethylene)-3,4-dihydro-6-methoxy-3-(4-methoxyphenyl)-,
4(3H)-quinazolinone, 3-(2,4-dimethoxyphenyl)-6-nitro-2-[[4-(2-pyridinyl)-1-piperazinyl]methyl]-
4(3H)-quinazolinone, 2-[[4-(3-chlorophenyl)-1-piperazinyl]methyl]-3-(2,4-dimethoxyphenyl)-6-nitro-
1-piperazinecarboxylic acid, 4-[[3-(2,4-dimethoxyphenyl)-3,4-dihydro-6-nitro-4-oxo-2-quinazolinyl]methyl]-, ethyl ester
3-(2-methoxyphenyl)-2-({[5-(1-pyrrolidinylcarbonyl)-1,3-benzothiazol-2-yl]sulfanyl}methyl)-4(3H)-quinazolinone
4-methyl-5H-pyrido[1',2':1,2]pyrimido[4,5-b]acridine-7,15-dione
1-(4-Methoxyphenyl)-4-phenyl-1,2,4-triazolo[4,3-a]quinazolin-5(4H)-one
4-[(2,5-DICHLOROPHENYL)AZO]-N-(2,3-DIHYDRO-1,3-DIOXO-2-METHYL-1H-BENZ[de]ISOQUINOLIN-5-YL)-3-HYDROXY-2-NAPHTHAMIDE
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and Biological Activity of Peptide Derivatives of Iodoquinazolinones/Nitroimidazoles | Molecules | 2008 |
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.